{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:08:11Z","timestamp":1790611691528,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["COVID19F01"],"award-info":[{"award-number":["COVID19F01"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In view of accumulating case reports of thyroid dysfunction following COVID-19 vaccination, we evaluated the risks of incident thyroid dysfunction following inactivated (CoronaVac) and mRNA (BNT162b2) COVID-19 vaccines using a population-based dataset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We identified people who received COVID-19 vaccination between 23 February and 30 September 2021 from a population-based electronic health database in Hong Kong, linked to vaccination records. Thyroid dysfunction encompassed anti-thyroid drug (ATD)\/levothyroxine (LT4) initiation, biochemical picture of hyperthyroidism\/hypothyroidism, incident Graves\u2019 disease (GD), and thyroiditis. A self-controlled case series design was used to estimate the incidence rate ratio (IRR) of thyroid dysfunction in a 56-day post-vaccination period compared to the baseline period (non-exposure period) using conditional Poisson regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 2,288,239 people received at least one dose of COVID-19 vaccination (57.8% BNT162b2 recipients and 42.2% CoronaVac recipients). 94.3% of BNT162b2 recipients and 92.2% of CoronaVac recipients received the second dose. Following the first dose of COVID-19 vaccination, there was no increase in the risks of ATD initiation (BNT162b2: IRR 0.864, 95% CI 0.670\u20131.114; CoronaVac: IRR 0.707, 95% CI 0.549\u20130.912), LT4 initiation (BNT162b2: IRR 0.911, 95% CI 0.716\u20131.159; CoronaVac: IRR 0.778, 95% CI 0.618\u20130.981), biochemical picture of hyperthyroidism (BNT162b2: IRR 0.872, 95% CI 0.744\u20131.023; CoronaVac: IRR 0.830, 95% CI 0.713\u20130.967) or hypothyroidism (BNT162b2: IRR 1.002, 95% CI 0.838\u20131.199; CoronaVac: IRR 0.963, 95% CI 0.807\u20131.149), GD, and thyroiditis. Similarly, following the second dose of COVID-19 vaccination, there was no increase in the risks of ATD initiation (BNT162b2: IRR 0.972, 95% CI 0.770\u20131.227; CoronaVac: IRR 0.879, 95%CI 0.693\u20131.116), LT4 initiation (BNT162b2: IRR 1.019, 95% CI 0.833\u20131.246; CoronaVac: IRR 0.768, 95% CI 0.613\u20130.962), hyperthyroidism (BNT162b2: IRR 1.039, 95% CI 0.899\u20131.201; CoronaVac: IRR 0.911, 95% CI 0.786\u20131.055), hypothyroidism (BNT162b2: IRR 0.935, 95% CI 0.794\u20131.102; CoronaVac: IRR 0.945, 95% CI 0.799\u20131.119), GD, and thyroiditis. Age- and sex-specific subgroup and sensitivity analyses showed consistent neutral associations between thyroid dysfunction and both types of COVID-19 vaccines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our population-based study showed no evidence of vaccine-related increase in incident hyperthyroidism or hypothyroidism with both BNT162b2 and CoronaVac.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-022-02548-1","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T20:02:17Z","timestamp":1665691337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-6071","authenticated-orcid":false,"given":"Carlos King Ho","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9813-1126","authenticated-orcid":false,"given":"David Tak Wai","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9418-7448","authenticated-orcid":false,"given":"Xi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1513-8726","authenticated-orcid":false,"given":"Celine Sze Ling","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9121-1959","authenticated-orcid":false,"given":"Francisco Tsz Tsun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4836-7808","authenticated-orcid":false,"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6275-1147","authenticated-orcid":false,"given":"Eric Yuk Fai","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6233-9144","authenticated-orcid":false,"given":"Ching Lung","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7569-409X","authenticated-orcid":false,"given":"Chi Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Cho","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5904-8322","authenticated-orcid":false,"given":"Ivan Chi Ho","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1669-4479","authenticated-orcid":false,"given":"Matthew Shing Hin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7818-1575","authenticated-orcid":false,"given":"Franco Wing Tak","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9037-0416","authenticated-orcid":false,"given":"Kathryn Choon Beng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8242-0014","authenticated-orcid":false,"given":"Ian Chi Kei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"key":"2548_CR1","unstructured":"World Health Organization. WHO coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int\/. Accessed 24 Mar 2022."},{"key":"2548_CR2","doi-asserted-by":"publisher","first-page":"102792","DOI":"10.1016\/j.jaut.2021.102792","volume":"127","author":"A Haque","year":"2022","unstructured":"Haque A, Pant AB. Mitigating COVID-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy. J Autoimmun. 2022;127:102792.","journal-title":"J Autoimmun"},{"key":"2548_CR3","doi-asserted-by":"publisher","first-page":"708333","DOI":"10.3389\/fendo.2021.708333","volume":"12","author":"H Inaba","year":"2021","unstructured":"Inaba H, Aizawa T. Coronavirus disease 2019 and the thyroid - progress and perspectives. Front Endocrinol (Lausanne). 2021;12:708333.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2548_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12020-021-02770-6","volume":"73","author":"AK Murugan","year":"2021","unstructured":"Murugan AK, Alzahrani AS. SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves\u2019disease. Endocrine. 2021;73(2):243\u201354.","journal-title":"Endocrine"},{"issue":"8","key":"2548_CR5","doi-asserted-by":"publisher","first-page":"e244909","DOI":"10.1136\/bcr-2021-244909","volume":"14","author":"RS Knack","year":"2021","unstructured":"Knack RS, Hanada T, Knack RS, Mayr K. Hashimoto\u2019s thyroiditis following SARS-CoV-2 infection. BMJ Case Rep. 2021;14(8):e244909.","journal-title":"BMJ Case Rep"},{"issue":"7","key":"2548_CR6","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s40618-020-01276-8","volume":"43","author":"R Pal","year":"2020","unstructured":"Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43(7):1027\u201331.","journal-title":"J Endocrinol Invest"},{"key":"2548_CR7","doi-asserted-by":"publisher","first-page":"778964","DOI":"10.3389\/fpubh.2021.778964","volume":"9","author":"DTW Lui","year":"2021","unstructured":"Lui DTW, Lee KK, Lee CH, Lee ACH, Hung IFN, Tan KCB. Development of Graves\u2019 disease after SARS-CoV-2 mRNA vaccination: a case report and literature review. Front Public Health. 2021;9:778964.","journal-title":"Front Public Health"},{"issue":"1","key":"2548_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12020-021-02919-3","volume":"75","author":"L di Filippo","year":"2022","unstructured":"di Filippo L, Castellino L, Giustina A. Occurrence and response to treatment of Graves\u2019 disease after COVID vaccination in two male patients. Endocrine. 2022;75(1):19\u201321.","journal-title":"Endocrine"},{"issue":"12","key":"2548_CR9","doi-asserted-by":"publisher","first-page":"e05217","DOI":"10.1002\/ccr3.5217","volume":"9","author":"M Giusti","year":"2021","unstructured":"Giusti M, Maio A. Acute thyroid swelling with severe hypothyroid myxoedema after COVID-19 vaccination. Clin Case Rep. 2021;9(12):e05217.","journal-title":"Clin Case Rep"},{"key":"2548_CR10","doi-asserted-by":"publisher","first-page":"617089","DOI":"10.3389\/fimmu.2020.617089","volume":"11","author":"A Vojdani","year":"2020","unstructured":"Vojdani A, Vojdani E, Kharrazian D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol. 2020;11:617089.","journal-title":"Front Immunol"},{"key":"2548_CR11","first-page":"150","volume":"7","author":"A Watad","year":"2016","unstructured":"Watad A, David P, Brown S, Shoenfeld Y. Autoimmune\/inflammatory syndrome induced by adjuvants and thyroid autoimmunity. Front Endocrinol (Lausanne). 2016;7:150.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2548_CR12","doi-asserted-by":"publisher","unstructured":"Jafarzadeh A, Nemati M, Jafarzadeh S, Nozari P, Mortazavi SMJ. Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence. J Endocrinol Invest. 2022:1\u201329. https:\/\/doi.org\/10.1007\/s40618-022-01786-7.","DOI":"10.1007\/s40618-022-01786-7"},{"issue":"11","key":"2548_CR13","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1136\/gutjnl-2018-317714","volume":"68","author":"KS Cheung","year":"2019","unstructured":"Cheung KS, Chen L, Chan EW, Seto WK, Wong ICK, Leung WK. Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187 897 patients. Gut. 2019;68(11):1979\u201385.","journal-title":"Gut"},{"issue":"5","key":"2548_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1089\/thy.2021.0684","volume":"32","author":"X Xiong","year":"2022","unstructured":"Xiong X, Wong CKH, Au ICH, Lai FTT, Li X, Wan EYF, et al. Safety of inactivated and mRNA COVID-19 vaccination among patients treated for hypothyroidism: a population-based cohort study. Thyroid. 2022;32(5):505\u201314.","journal-title":"Thyroid"},{"issue":"4","key":"2548_CR15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/annrheumdis-2021-221571","volume":"81","author":"X Li","year":"2022","unstructured":"Li X, Tong X, Yeung WWY, Kuan P, Yum SHH, Chui CSL, et al. Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong. Ann Rheum Dis. 2022;81(4):564\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2548_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1473-3099(21)00451-5","volume":"22","author":"EYF Wan","year":"2022","unstructured":"Wan EYF, Chui CSL, Lai FTT, Chan EWY, Li X, Yan VKC, et al. Bell\u2019s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet Infect Dis. 2022;22(1):64\u201372.","journal-title":"Lancet Infect Dis"},{"key":"2548_CR17","doi-asserted-by":"publisher","unstructured":"Chua GT, Kwan MYW, Chui CSL, Smith RD, Cheung EC, Tian T, et al. Epidemiology of acute myocarditis\/pericarditis in hong kong adolescents following comirnaty vaccination. Clin Infect Dis. 2021. https:\/\/doi.org\/10.1093\/cid\/ciab989.","DOI":"10.1093\/cid\/ciab989"},{"issue":"3","key":"2548_CR18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.7326\/M21-3700","volume":"175","author":"FTT Lai","year":"2022","unstructured":"Lai FTT, Li X, Peng K, Huang L, Ip P, Tong X, et al. Carditis after COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine : a case-control study. Ann Intern Med. 2022;175(3):362\u201370.","journal-title":"Ann Intern Med"},{"issue":"4","key":"2548_CR19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ajh.26478","volume":"97","author":"CW Sing","year":"2022","unstructured":"Sing CW, Tang CTL, Chui CSL, Fan M, Lai FTT, Li X, et al. COVID-19 vaccines and risks of hematological abnormalities: nested case-control and self-controlled case series study. Am J Hematol. 2022;97(4):470\u201380.","journal-title":"Am J Hematol"},{"key":"2548_CR20","doi-asserted-by":"publisher","first-page":"100393","DOI":"10.1016\/j.lanwpc.2022.100393","volume":"21","author":"EYF Wan","year":"2022","unstructured":"Wan EYF, Chui CSL, Wang Y, Ng VWS, Yan VKC, Lai FTT, et al. Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: a self-controlled case series and nested case-control study. Lancet Reg Health West Pac. 2022;21:100393.","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"2548_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12916-022-02321-4","volume":"20","author":"CKH Wong","year":"2022","unstructured":"Wong CKH, Xiong X, Lau KTK, Chui CSL, Lai FTT, Li X, et al. Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization. BMC Med. 2022;20(1):119.","journal-title":"BMC Med"},{"issue":"1","key":"2548_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41467-022-28068-3","volume":"13","author":"FTT Lai","year":"2022","unstructured":"Lai FTT, Huang L, Chui CSL, Wan EYF, Li X, Wong CKH, et al. Multimorbidity and adverse events of special interest associated with COVID-19 vaccines in Hong Kong. Nat Commun. 2022;13(1):411.","journal-title":"Nat Commun"},{"issue":"6","key":"2548_CR23","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/joim.13453","volume":"291","author":"FTT Lai","year":"2022","unstructured":"Lai FTT, Huang L, Peng K, Li X, Chui CSL, Wan EYF, et al. Post-COVID-19-vaccination adverse events and healthcare utilization among individuals with or without previous SARS-CoV-2 infection. J Intern Med. 2022;291(6):864\u20139.","journal-title":"J Intern Med"},{"issue":"1","key":"2548_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/22221751.2022.2050952","volume":"11","author":"FTT Lai","year":"2022","unstructured":"Lai FTT, Chua GT, Chan EWW, Huang L, Kwan MYW, Ma T, et al. Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study. Emerg Microbes Infect. 2022;11(1):885\u201393.","journal-title":"Emerg Microbes Infect"},{"key":"2548_CR25","doi-asserted-by":"publisher","unstructured":"Li X, Tong X, Wong ICK, Peng K, Chui CSL, Lai FTT, et al. Lack of inflammatory bowel disease flare-up following two-dose BNT162b2 vaccine: a population-based cohort study. Gut. 2022. https:\/\/doi.org\/10.1136\/gutjnl-2021-326860.","DOI":"10.1136\/gutjnl-2021-326860"},{"key":"2548_CR26","doi-asserted-by":"publisher","first-page":"101504","DOI":"10.1016\/j.eclinm.2022.101504","volume":"50","author":"CSL Chui","year":"2022","unstructured":"Chui CSL, Fan M, Wan EYF, Leung MTY, Cheung E, Yan VKC, et al. Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: a self-controlled case series study. EClinicalMedicine. 2022;50:101504.","journal-title":"EClinicalMedicine"},{"key":"2548_CR27","doi-asserted-by":"publisher","unstructured":"Wong CKH, Mak LY, Au ICH, Lai FTT, Li X, Wan EYF, et al. Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines. J Hepatol. 2022. https:\/\/doi.org\/10.1016\/j.jhep.2022.06.032.","DOI":"10.1016\/j.jhep.2022.06.032"},{"issue":"11","key":"2548_CR28","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/oxfordjournals.aje.a008695","volume":"143","author":"CP Farrington","year":"1996","unstructured":"Farrington CP, Nash J, Miller E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol. 1996;143(11):1165\u201373.","journal-title":"Am J Epidemiol"},{"key":"2548_CR29","doi-asserted-by":"publisher","first-page":"n1931","DOI":"10.1136\/bmj.n1931","volume":"374","author":"J Hippisley-Cox","year":"2021","unstructured":"Hippisley-Cox J, Patone M, Mei XW, Saatci D, Dixon S, Khunti K, et al. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ. 2021;374:n1931.","journal-title":"BMJ"},{"issue":"7","key":"2548_CR30","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41591-021-01408-4","volume":"27","author":"CR Simpson","year":"2021","unstructured":"Simpson CR, Shi T, Vasileiou E, Katikireddi SV, Kerr S, Moore E, et al. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nat Med. 2021;27(7):1290\u20137.","journal-title":"Nat Med"},{"key":"2548_CR31","doi-asserted-by":"publisher","first-page":"e068373","DOI":"10.1136\/bmj-2021-068373","volume":"376","author":"X Li","year":"2022","unstructured":"Li X, Ravent\u00f3s B, Roel E, Pistillo A, Martinez-Hernandez E, Delmestri A, et al. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ. 2022;376:e068373.","journal-title":"BMJ"},{"issue":"12","key":"2548_CR32","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","volume":"27","author":"M Patone","year":"2021","unstructured":"Patone M, Handunnetthi L, Saatci D, Pan J, Katikireddi SV, Razvi S, et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021;27(12):2144\u201353.","journal-title":"Nat Med"},{"issue":"11","key":"2548_CR33","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1080\/21645515.2021.1947102","volume":"17","author":"M Sahin Tekin","year":"2021","unstructured":"Sahin Tekin M, Saylisoy S, Yorulmaz G. Subacute thyroiditis following COVID-19 vaccination in a 67-year-old male patient: a case report. Hum Vaccin Immunother. 2021;17(11):4090\u20132.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"2548_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s40618-021-01650-0","volume":"45","author":"G Zettinig","year":"2022","unstructured":"Zettinig G, Krebs M. Two further cases of Graves\u2019 disease following SARS-Cov-2 vaccination. J Endocrinol Invest. 2022;45(1):227\u20138.","journal-title":"J Endocrinol Invest"},{"key":"2548_CR35","doi-asserted-by":"publisher","first-page":"i4515","DOI":"10.1136\/bmj.i4515","volume":"354","author":"I Petersen","year":"2016","unstructured":"Petersen I, Douglas I, Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs. BMJ. 2016;354:i4515.","journal-title":"BMJ"},{"key":"2548_CR36","volume-title":"The self-controlled case series method","author":"GW Yonas","year":"2022","unstructured":"Yonas GW, Heather W, Paddy F. The self-controlled case series method: The Comprehensive R Archive Network; 2022. https:\/\/cran.r-project.org\/web\/packages\/SCCS\/SCCS.pdf. Accessed 24 Aug 2022"},{"issue":"10","key":"2548_CR37","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/sim.9325","volume":"41","author":"Y Ghebremichael-Weldeselassie","year":"2022","unstructured":"Ghebremichael-Weldeselassie Y, Jabagi MJ, Botton J, Bertrand M, Baricault B, Drouin J, et al. A modified self-controlled case series method for event-dependent exposures and high event-related mortality, with application to COVID-19 vaccine safety. Stat Med. 2022;41(10):1735\u201350.","journal-title":"Stat Med"},{"issue":"9","key":"2548_CR38","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1089\/thy.2021.0142","volume":"31","author":"O Vera-Lastra","year":"2021","unstructured":"Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP, Medina G, S\u00e1nchez Valadez TI, Jara LJ. Two cases of Graves\u2019 disease following SARS-CoV-2 vaccination: an autoimmune\/inflammatory syndrome induced by adjuvants. Thyroid. 2021;31(9):1436\u20139.","journal-title":"Thyroid"},{"key":"2548_CR39","volume-title":"Graves\u2019 disease","author":"B Pokhrel","year":"2022","unstructured":"Pokhrel B, Bhusal K. Graves\u2019 disease: StatPearls Publishing. Treasure Island (FL); 2022."},{"issue":"16","key":"2548_CR40","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"Smith TJ, Heged\u00fcs L. Graves\u2019 disease. N Engl J Med. 2016;375(16):1552\u201365.","journal-title":"N Engl J Med"},{"issue":"6","key":"2548_CR41","doi-asserted-by":"publisher","first-page":"e2324","DOI":"10.1210\/clinem\/dgac119","volume":"107","author":"YJ Chee","year":"2022","unstructured":"Chee YJ, Liew H, Hoi WH, Lee Y, Lim B, Chin HX, et al. SARS-CoV-2 mRNA vaccination and Graves\u2019 disease: a report of 12 cases and review of the literature. J Clin Endocrinol Metab. 2022;107(6):e2324\u201330.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2548_CR42","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s40618-022-01767-w","volume":"45","author":"G Yorulmaz","year":"2022","unstructured":"Yorulmaz G, Sahin Tekin M. SARS-CoV-2 vaccine-associated subacute thyroiditis. J Endocrinol Invest. 2022;45(7):1341\u20137.","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2548_CR43","doi-asserted-by":"publisher","first-page":"e1823","DOI":"10.1210\/clinem\/dgac049","volume":"107","author":"SH Oguz","year":"2022","unstructured":"Oguz SH, Sendur SN, Iremli BG, Gurlek A, Erbas T, Unluturk U. SARS-CoV-2 vaccine-induced thyroiditis: safety of revaccinations and clinical follow-up. J Clin Endocrinol Metab. 2022;107(5):e1823\u201334.","journal-title":"J Clin Endocrinol Metab"},{"key":"2548_CR44","doi-asserted-by":"publisher","first-page":"840668","DOI":"10.3389\/fendo.2022.840668","volume":"13","author":"SA Paschou","year":"2022","unstructured":"Paschou SA, Karalis V, Psaltopoulou T, Vasileiou V, Charitaki I, Bagratuni T, et al. Patients with autoimmune thyroiditis present similar immunological response to COVID-19 BNT162b2 mRNA vaccine with healthy subjects, while vaccination may affect thyroid function: a clinical study. Front Endocrinol (Lausanne). 2022;13:840668.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2548_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s12020-021-02902-y","volume":"74","author":"C Sriphrapradang","year":"2021","unstructured":"Sriphrapradang C, Shantavasinkul PC. Graves\u2019 disease following SARS-CoV-2 vaccination. Endocrine. 2021;74(3):473\u20134.","journal-title":"Endocrine"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02548-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02548-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02548-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T20:02:25Z","timestamp":1665691345000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02548-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2548"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02548-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742366321.793597632","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the University of Hong Kong\/Hospital Authority Hong Kong West Cluster (UW 21-149 and UW 21-138); and the Department of Health Ethics Committee (LM 21\/2021). All data were anonymised, and the project was granted waiver of participant consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Carlos King Ho Wong reports receipt of research funding from the EuroQoL Group Research Foundation, the Hong Kong Research Grants Council, and the Hong Kong Health and Medical Research Fund. Francisco Tsz Tsun Lai has been supported by the RGC Postdoctoral Fellowship under the Hong Kong Research Grants Council. Xue Li has received research grants from the Food and Health Bureau of the Government of the Hong Kong SAR, research and educational grants from Janssen and Pfizer; internal funding from University of Hong Kong; and consultancy fee from Merck Sharp & Dohme, unrelated to this work. Eric Yuk Fai Wan has received research grants from the Food and Health Bureau of the Government of the Hong Kong SAR and the Hong Kong Research Grants Council, outside the submitted work. Celine Sze Ling Chui has received grants from the Food and Health Bureau of the Hong Kong Government, Hong Kong Research Grant Council, Hong Kong Innovation and Technology Commission, Pfizer, IQVIA, and Amgen, and personal fee from Primevigilance Ltd., outside the submitted work. Esther Wai Yin Chan reports honorarium from Hospital Authority, grants from Research Grants Council (RGC, Hong Kong), grants from Research Fund Secretariat of the Food and Health Bureau, grants from National Natural Science Fund of China, grants from Wellcome Trust, grants from Bayer, grants from Bristol-Myers Squibb, grants from Pfizer, grants from Janssen, grants from Amgen, grants from Takeda, and grants from Narcotics Division of the Security Bureau of HKSAR, outside the submitted work. Ian Chi Kei Wong reports research funding outside the submitted work from Amgen, Bristol-Myers Squibb, Pfizer, Janssen, Bayer, GSK, Novartis, the Hong Kong RGC, and the Hong Kong Health and Medical Research Fund, National Institute for Health Research in England, European Commission, National Health and Medical Research Council in Australia, and also received speaker fees from Janssen and Medice in the previous 3 years, all outside the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"339"}}